| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
7.742 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
CNN1 |
CNN1: Calponin-1 |
7.742 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
CNN2 |
CNN2: Calponin-2 |
7.74 |
Evidence |
|
| HIST3H3 |
HIST3H3, H3FT: Histone H3.1t |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
7.737 |
Evidence |
|
| STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
STK3 |
STK3, MST2: Serine/threonine-protein kinase 3 |
7.737 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
CNN3 |
CNN3: Calponin-3 |
7.737 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
7.737 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
7.737 |
Evidence |
|
| NR1D1 |
NR1D1, EAR1, HREV, THRAL: Orphan nuclear receptor NR1D1 |
CLTC |
CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 |
7.737 |
Evidence |
|
| ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
7.737 |
Evidence |
|
| ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
7.737 |
Evidence |
|
| EGR1 |
EGR1, ZNF225: Early growth response protein 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
7.737 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
7.737 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
7.737 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
7.737 |
Evidence |
|
| FABP4 |
FABP4: Fatty acid-binding protein, adipocyte |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
7.737 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
AQP2 |
AQP2: Aquaporin-2 |
7.737 |
Evidence |
|
| MYL4 |
MYL4, MLC1, PRO1957: Myosin light polypeptide 4 |
RIN1 |
RIN1: Ras and Rab interactor 1 |
7.737 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SIPA1L1 |
SIPA1L1, E6TP1, KIAA0440: Signal-induced proliferation-associated 1-like protein |
7.737 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
7.737 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
7.737 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
HIST1H1B |
HIST1H1B, H1F5: Histone H1.5 |
7.737 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PITPNM1 |
PITPNM1: Uncharacterized protein PITPNM1 |
7.737 |
Evidence |
|
| SORBS3 |
SORBS3, SCAM1: Vinexin |
FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
7.737 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
7.737 |
Evidence |
|